Brian Frawley is a partner in Sullivan & Cromwell’s Litigation Group. His practice focuses on a broad range of complex securities, derivative and commercial litigation, as well as the defense of significant regulatory matters.
Mr. Frawley regularly counsels clients in litigation arising out of mergers and acquisitions, including recent transactions involving Anheuser-Busch InBev, AT&T, Bayer, Columbia Pipeline, Cytec Industries, DISH Networks, Forest City Realty, KCG Holdings, Merck KGaA, NorthStar Asset Management, Novartis, Seattle Genetics, Solera Holdings, Sotheby’s, Tiffany, and Tokio Marine, among others. He also frequently represents financial advisors in disputes arising out of mergers or acquisitions, including Barclays, Centerview, Houlihan Lokey, and Lazard, among others.
